MINOCA SYNDROME

By Paulina Maldonado
Universidad De Durango, Chihuahua, Mexico
Houston, Texas.
Amin H. Karim MD
Baylor College of Medicine and
Methodist Institute of Academic Medicine, Houston, Texas

A 65 year old patient presented, disabled from old cerebro vascular accident causing flaccid left sided hemiplegia with contractures, admitted to hospital for change of mental status; he developed hypotension; EKG showed ST elevation in II, III and aVF as well as V3V4V5 diagnostic of inferior wall myocardial infarction with lateral extension.

He was rushed to the cath lab where cardiac catheterization showed what looked like “normal coronary arteries”.

His high sensitivity peaked at 1200. He was treated with intravenous heparin and beta blockers; he remained hemodynamically stable and was discharged.

Myocardial Infarction with nonobstructive coronary atherosclerosis

Although the occurrence was initially reported about 80 years ago a very small number of patients are found to have MINOCA.  

The term MINOCA is reserved for patients with elevated troponin associated with myocardial ischemia at presentation and should not include disorders with non ischemic elevated troponin. 

It is important to mention and reiterate that MINOCA should not be considered a final diagnosis but rather a working one that requires further testing. 

Epidemiology

The incidence of MINOCA varied from 1% to 15% and roughly 6% of all Acute Myocardial Infarction cases. 

  1. Younger (18-55)
  2. Female
  3. lower prevalence of hyperlipidemia
  4. ⅓ presented with ST segment elevation of myocardial infarction

Pathogenesis:

MINOCA is heterogenous and can be divided into coronary, cardiac and extra cardiac causes. Ischemia happens during a temporary suspension of blood flow to the myocardium and it takes place in the epicardial arteries or the microvasculature. 

CoronaryCardiacExtra cardiac 
plaque rupture or erosionMyocarditisstroke
coronary spasmTakotsubo syndromepulmonary embolism
spontaneous coronary artery dissectioncardiomyopathiessepsis
coronary embolizationcardiac traumarenal failure
coronary microvascular disorderstachyarrhythmiashypoxemia

Risk factors:

  • Associated with Long term major adverse cardiovascular events after MINOCA including ST segment elevation on a presenting Electrocardiogram
  • older age
  • reduced left ventricular ejection fraction
  • diabetes mellitus
  • hypertension
  • tobacco use
  • prior Myocardial infarction
  • Stroke
  • peripheral artery disease
  • chronic obstructive pulmonary disease
  • chronic kidney disease
  • lower total cholesterol
  • Peak troponin
  • Depression at the time of MINOCA 

Signs and Symptoms:

  • Chest pain/chest pressure / chest heaviness
  • Nausea
  • jaw, neck or upper back pain
  • pain or pressure in the lower chest or upper abdomen
  • shortness of breath
  • fainting
  • indigestion
  • fatigue

Diagnostics:

Requires a comprehensive diagnostic workup. Is the first line diagnostic tool to detect non obstructive epicardial coronary arteries (less than 50% stenosis) in the setting of an Myocardial Infarction.

Imagining modalities are vital in diagnosing and identifying the underlying mechanisms of MINOCA.

Coronary intravascular imaging

With Intravascular Ultrasound 40% cases and Optical Coherence Tomography 50% cases  is essential to diagnose plaque disruption.

It should be performed at the time of coronary angiography for Acute Myocardial Infarction in all 3 major epicardial arteries. 

Cardiac Imaging

Transthoracic echocardiography used in the assessment of cardiac function after a MINOCA. It can be used in the diagnosis of Takotsubo cardiomyopathy and non ischemic cardiomyopathy specifically to demonstrate recovery of left ventricular function.

Transesophageal echocardiography can be used when coronary embolism is suspected.

Cardiac Magnetic Resonance Imagining (CMRI) provides a diagnosis in 74-87% of all MINOCA patients. 

  • Subendocardial (or transmural) pattern of myocardial edema, inflammation or fibrosis is suggested of ischemic Myocardial Infarction.
  • Epicardial pattern is suggestive of non ischemic Myocardial Infarction.

Echocardiogram can be used to diagnose Takotsubo  cardiomyopathy and non ischemic cardiomyopathy, but CMRI can only be used to detect myocarditis.

Myocardial perfusion quantification with adenosine or regadenoson can be used to diagnose coronary microvascular dysfunction non invasively.

The timing to perform a CMRI is important; it should be completed as close to the acute myocardial infarction as possible. CMRI carries not only diagnostic value but prognostic value as well. 

Multimodality approach

OCT and CMRI together resulted in a diagnosis in 85% of the cases whereas Optical Coherence Tomography alone was only 46% and Cardiac Magnetic Resonance Imagining 74%. 

Treatment

It should me customized to the underlying diagnosis:

MedsUnderlying diagnosis
Aspirin and High intensity statinsPlaque disruption
dual antiplatelet therapy by adding ticagrelor for less than 1 monthPlaque disruption not undergoing stenting
Beta blocker and renin angiotensin system inhibitorsleft ventricular dysfunction
Long acting calcium channel antagonist (dihydropyridine and nondihydropyridine)MINOCA patients secondary to epicardial coronary vasospasm
nitrates can be added to calcium channel antagonistsrefractory variant angina
antithrombotic agents coronary embolism or thrombosis
targeted therapiesunderlying thrombophilia
conservative management (avoiding increased risk of complications with intervention)spontaneous coronary artery dissection
Percutaneous coronary interventionSTEMI, cardiogenic shock, ongoing ischemia
aspirin, beta blocker, statin and renin angiotensin system spontaneous coronary artery dissection (should be assessed based on individual risk factors
antianginal treatment with b blockers, calcium, channel antagonists and ranolazineChest pain
MINOCA mimickersHeart failure
mechanical circulatory supportprogressive circulatory failure
resolves in most patients within 2-4 weeksMyocarditis, but if they develop arrhythmia and persistent cardiac dysfunction medical therapy should be administered.
antivirals and immunosuppressivesunderlying etiologies

Prognosis:

Short and long term mortality

At 1 year follow up, MINOCA mortality is 2 to 5%.

Among individuals 65 and older the risk of adverse outcomes is higher 12%

Possible Reinfarction

only occurs in 1.3 to 2.6% of patients at 1 year and 7.1% at 4 years.

Quality of life

Identified factors that increase the risk of Major advance cardiac event:

  • older age
  • hypertension
  • smoking
  • reduced ejection fraction
  • chronic obstructive pulmonary disease
  • elevated creatinine 
  • cancer 
  • elevated CRP

Requires further investigation that may require longer hospitalizations. It is commonly found that Myocardial Infarctions is missed in women due to non classic presentations such as shortness of breath, dizziness, nausea or unusual fatigue. Patients with MINOCA do present with recurrent chest pains without myocardial infarction.

Literature Cited: 

Unknown's avatar

Author: Amin H. Karim MD

Graduate of Dow Medical College Class of 1977.

Leave a comment